Morgan Stanley Downgrades Stride to Equal-Weight, Announces $46 Price Target
Morgan Stanley analyst Greg Parrish downgrades Stride (NYSE:LRN) from Overweight to Equal-Weight and announces $46 price target.
Piper Sandler Upgrades KeyCorp to Neutral, Lowers Price Target to $16.5
Piper Sandler analyst Scott Siefers upgrades KeyCorp (NYSE:KEY) from Underweight to Neutral and lowers the price target from $18.5 to $16.5.
Truist Securities Downgrades SVB Finl Gr to Hold, Lowers Price Target to $100
Truist Securities analyst Brandon King downgrades SVB Finl Gr (NASDAQ:SIVB) from Buy to Hold and lowers the price target from $174 to $100.
UBS Downgrades Caterpillar to Sell, Lowers Price Target to $225
UBS analyst Steven Fisher downgrades Caterpillar (NYSE:CAT) from Neutral to Sell and lowers the price target from $230 to $225.
Piper Sandler Downgrades a.k.a. Brands Holding to Neutral, Lowers Price Target to $2
Piper Sandler analyst Edward Yruma downgrades a.k.a. Brands Holding (NYSE:AKA) from Overweight to Neutral and lowers the price target from $3 to $2.
Berenberg Maintains Buy on Merck & Co, Raises Price Target to $130
Berenberg analyst Luisa Hector maintains Merck & Co (NYSE:MRK) with a Buy and raises the price target from $125 to $130.
HC Wainwright & Co. Reiterates Buy on aTyr Pharma, Maintains $35 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates aTyr Pharma (NASDAQ:LIFE) with a Buy and maintains $35 price target.
HC Wainwright & Co. Reiterates Buy on Aldeyra Therapeutics, Maintains $15 Price Target
HC Wainwright & Co. analyst Matthew Caufield reiterates Aldeyra Therapeutics (NASDAQ:ALDX) with a Buy and maintains $15 price target.
Citigroup Maintains Buy on Enphase Energy, Raises Price Target to $285
Citigroup analyst Vikram Bagri maintains Enphase Energy (NASDAQ:ENPH) with a Buy and raises the price target from $205 to $285.
HC Wainwright & Co. Maintains Buy on Olema Pharmaceuticals, Raises Price Target to $15
HC Wainwright & Co. analyst Emily Bodnar maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and raises the price target from $12 to $15.